Celsion Announces Potent, Durable Preclinical Lung Expression Data for Its Novel TheraSilence RNA Program
May 21, 2015 at 08:03 AM EDT
Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer ...
